Joelf Posted February 15 Share Posted February 15 Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis. Analysis of immune cell parameters has identified abnormalities that likely reflect disease pathogenesis and that are candidate biomarkers for sub-classification and targeted treatment. PubMed, Arthritis Res Ther, 2021 Jan 6;23(1):10. (Also see B Cells and T Cells) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles. Quote Link to post Share on other sites
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.